Unstable Mechanisms of Resistance to Inhibitors of <named-content content-type="genus-species">Escherichia coli</named-content> Lipoprotein Signal Peptidase

ABSTRACT Clinical development of antibiotics with novel mechanisms of action to kill pathogenic bacteria is challenging, in part, due to the inevitable emergence of resistance. A phenomenon of potential clinical importance that is broadly overlooked in preclinical development is heteroresistance, an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Homer Pantua, Elizabeth Skippington, Marie-Gabrielle Braun, Cameron L. Noland, Jingyu Diao, Yutian Peng, Susan L. Gloor, Donghong Yan, Jing Kang, Anand Kumar Katakam, Janina Reeder, Georgette M. Castanedo, Keira Garland, Laszlo Komuves, Meredith Sagolla, Cary D. Austin, Jeremy Murray, Yiming Xu, Zora Modrusan, Min Xu, Emily J. Hanan, Sharookh B. Kapadia
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
Lpp
Acceso en línea:https://doaj.org/article/ad7dc0127d394ca78d233d455e860331
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!